253 related articles for article (PubMed ID: 19374934)
1. Nebulous humors: defining alloantibodies in the 21st century.
Warner P
Hum Immunol; 2009 Aug; 70(8):623-6. PubMed ID: 19374934
[No Abstract] [Full Text] [Related]
2. Which human leukocyte antigen antibodies are really clinically relevant?
Opelz G; Claas FH
Hum Immunol; 2009 Aug; 70(8):561-2. PubMed ID: 19580832
[No Abstract] [Full Text] [Related]
3. Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant.
Claas FH; Doxiadis II
Hum Immunol; 2009 Aug; 70(8):636-9. PubMed ID: 19375467
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.
Gupta A; Sinnott P
Hum Immunol; 2009 Aug; 70(8):618-22. PubMed ID: 19374932
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.
Poli F; Cardillo M; Scalamogna M
Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758
[TBL] [Abstract][Full Text] [Related]
6. Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation.
Taylor CJ; Kosmoliaptsis V; Summers DM; Bradley JA
Hum Immunol; 2009 Aug; 70(8):563-8. PubMed ID: 19445992
[TBL] [Abstract][Full Text] [Related]
7. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
8. Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums.
Gebel HM; Moussa O; Eckels DD; Bray RA
Hum Immunol; 2009 Aug; 70(8):610-7. PubMed ID: 19375473
[TBL] [Abstract][Full Text] [Related]
9. Minimising the clinical impact of the alloimmune response through effective histocompatibility testing for organ transplantation.
Dyer PA; Claas FH; Doxiadis II; Glotz D; Taylor CJ
Transpl Immunol; 2012 Oct; 27(2-3):83-8. PubMed ID: 22732444
[No Abstract] [Full Text] [Related]
10. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
Rose ML; Smith JD
Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
Eng HS; Bennett G; Bardy P; Coghlan P; Russ GR; Coates PT
Hum Immunol; 2009 Aug; 70(8):595-9. PubMed ID: 19527759
[TBL] [Abstract][Full Text] [Related]
12. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients.
Fuggle SV; Martin S
Transplantation; 2008 Aug; 86(3):384-90. PubMed ID: 18698240
[TBL] [Abstract][Full Text] [Related]
13. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
14. Subclinical Antibody-Mediated Rejection.
Arias M; Serón D; Herrero I; Rush DN; Wiebe C; Nickerson PW; Ussetti P; Rodrigo E; de Cos MA
Transplantation; 2017 Jun; 101(6S Suppl 1):S1-S18. PubMed ID: 28538291
[No Abstract] [Full Text] [Related]
15. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.
Stastny P; Ring S; Lu C; Arenas J; Han M; Lavingia B
Hum Immunol; 2009 Aug; 70(8):600-4. PubMed ID: 19375468
[TBL] [Abstract][Full Text] [Related]
16. Alloantibodies and outcomes of deceased donor kidney allografts.
Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
[TBL] [Abstract][Full Text] [Related]
17. Pre- and posttransplant monitoring of alloantibodies by complement-dependent cytotoxicity and luminex methodologies in liver transplantation.
Monteiro F; Rodrigues H; Kalil J; Castro MC; Panajotopoulos N; Paredes M; Massarolo P; Mies S
Transplant Proc; 2012 Oct; 44(8):2411-2. PubMed ID: 23026608
[TBL] [Abstract][Full Text] [Related]
18. Using real data for a virtual crossmatch.
Zachary AA; Sholander JT; Houp JA; Leffell MS
Hum Immunol; 2009 Aug; 70(8):574-9. PubMed ID: 19527762
[TBL] [Abstract][Full Text] [Related]
19. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD
Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
[TBL] [Abstract][Full Text] [Related]
20. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction.
Muro M; Llorente S; Gónzalez-Soriano MJ; Minguela A; Gimeno L; Alvarez-López MR
Clin Transpl; 2006; ():379-83. PubMed ID: 18365392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
